Proximagen Group - UK Operations' Unit Acquisition

Proximagen Group - UK Operations raised a round of funding on February 26, 2018. Investors include BenevolentAI.

Proximagen Group (AIM: PRX) is a biotechnology company focused on the development and commercialization of therapeutics for diseases of the central nervous system and inflammation.…

Articles about Proximagen Group - UK Operations' Unit Acquisition: